Your session is about to expire
← Back to Search
Nocebo for Fear of Movement (EchoKinésio Trial)
N/A
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour
Awards & highlights
EchoKinésio Trial Summary
This trial looks at how kinesiophobia (a fear of movement) affects people with chronic pain, specifically looking at the effect on the excitability of the nervous system and the association with top-down inhibitory mechanisms.
Eligible Conditions
- Fear of Movement
EchoKinésio Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 hour
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Corticospinal excitability
Secondary outcome measures
downward inhibition of pain
EchoKinésio Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: noceboExperimental Treatment1 Intervention
Ultrasound with fake results of rotator cuff injury.
Group II: placeboActive Control1 Intervention
Ultrasound with fake results of the healthy rotator cuff.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nocebo
2019
N/A
~160
Find a Location
Who is running the clinical trial?
Université de SherbrookeLead Sponsor
292 Previous Clinical Trials
69,417 Total Patients Enrolled
Guillaume Leonard, PrStudy DirectorUniversité de Sherbrooke
1 Previous Clinical Trials
50 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of epilepsy.You have a disorder affecting your brain or nervous system.You have Raynaud's syndrome.Only people who are in good health and not currently experiencing any medical conditions are eligible to participate.Do not take short-acting pain medications for 6 hours before participating in the study.You have a condition that causes you constant pain or discomfort.You are allergic to capsaicin.You have a skin condition.You have a problem with your shoulder.
Research Study Groups:
This trial has the following groups:- Group 1: nocebo
- Group 2: placebo
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there currently an open enrollment period for this clinical trial?
"The official listing on clinicaltrials.gov reveals that this trial is still actively seeking participants, having been posted in October 2021 and last revised in January 2022."
Answered by AI
To what extent has the sample size of this trial been expanded?
"Indeed, information available on clinicaltrials.gov declares that this medical trial is actively recruiting participants. Dating back to October 18th 2021 and as recently updated January 31st 2022, the study seeks 44 patients from a single site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger